14158 Results (Page 444 of 567)
All Market Research Reports
Africa Diabetes Drugs Market Analysis
The Africa diabetes drugs market size was valued at $926.7 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030 and will reach $1665 Mn in 2030. The market is segmented by drug type, application, and distribution channel. The African diabetes drug market will grow because the increasing prevalence of NCDs in Africa has contributed to the increasing prevalence of diabetes. The key market players are Johnson & Johnson, Novo Nordisk, Novartis, Merck, Eli Lilly and Company, and others.
Belgium Neurology Clinical Trials Market Analysis
The Belgium Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $17.7 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising prevalence of neurological disorders and a favourable regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include UCB, Biogen Inc & Icometrix.
Middle East Anti-Depressants Drugs Market Analysis
The Middle East Anti-Depressants drugs market size was valued at $3.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.64 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The Middle East Anti-Depressants drug market will grow because Depression is a common mental health disorder in the Middle East, affecting a significant portion of the population. The key market players are GlaxoSmithKline plc (GBR), AstraZeneca (GBR), Mallinckrodt (GBR), Novartis AG, and others.
Turkey Connected Healthcare Market Analysis
The Turkey-connected healthcare market is projected to grow from $530.88 Mn in 2022 to $4045.94 Mn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be growing healthcare expenditure, a large and ageing population and government initiatives. The market is segmented by type, function and by application. Some of the major players include Turkcell, Arcelik Healthcare, Acibadem Healthcare Group, Siemens Healthineers, Medtronic and GE Healthcare.
Thailand Connected Healthcare Market Analysis
The Thailand-connected healthcare market is projected to grow from $76.63 Mn in 2022 to $600.89 Mn by 2030, registering a CAGR of 28.74% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, increasing healthcare spending and government support. The market is segmented by type, function and by application. Some of the major players include Bumrungrad Hospital, Piyavate Hospital, Ramathibodi Hospital, Medtronic, Doctor Anywhere, and GE Healthcare.
Spain Connected Healthcare Market Analysis
The Spain-connected healthcare market is projected to grow from $1.28 Bn in 2022 to $8.89 Bn by 2030, registering a CAGR of 27.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, increasing demand for patient-centred care, growing digital health ecosystem and favourable government policies. The market is segmented by type, function and by application. Some of the major players include Telefonica, Primum Health, HumanITcare, Medtronic, Philips Healthcare and Siemens Healthineers.
South Korea Connected Healthcare Market Analysis
The South Korean connected healthcare market is projected to grow from $969.62 Mn in 2022 to $7622.15 Mn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing geriatric population, high-tech culture, government support and the COVID-19 pandemic. The market is segmented by type, function and by application. Some of the major players include Samsung, SK Telecom, Hanwha Group, Oracle, Philips Healthcare and GE Healthcare.
South Africa Connected Healthcare Market Analysis
The South Africa-connected healthcare market is projected to grow from $431.34 Mn in 2022 to $3239.25 Mn by 2030, registering a CAGR of 29.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be private sector investments, increasing healthcare expenditure, technological advancements and government support. The market is segmented by type, function and by application. Some of the major players include Clicks Group, Netcare, Quro Medical, Roche Diagnostics, Philips Healthcare and Medtronic.
Singapore Connected Healthcare Market Analysis
The Singapore-connected healthcare market is projected to grow from $79.63 Mn in 2022 to $610.67 Mn by 2030, registering a CAGR of 29% during the forecast period of 2022 - 2030. The main factors driving the growth would be a growing ageing population, technologically advanced infrastructure, growing start-up ecosystem and government support. The market is segmented by type, function and by application. Some of the major players include Doctor Anywhere, KroniKare, HiDoc, Siemens Healthineer, Philips Healthcare and Apple.
Germany Alexipharmic Drugs Market Analysis
Germany's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 2.90% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Germany Alexipharmic Drugs market will grow because of growing awareness in Germany about the risks of poisoning and the importance of having quick access to antidotes in case of an emergency. The key market players are Merck KGaA (DEU), CSL Behring (DEU), Grifols Deutschland (DEU), Wockhardt GmbH (DEU), B. Braun Melsungen AG (DEU), and others.
Europe Alexipharmic Drugs Market Analysis
Europe's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 3.44% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Europe Alexipharmic Drugs market will grow because of the rising prevalence of various forms of chronic conditions and overdosing on prescription medications. The key market players are Bausch Health Companies Inc (Canada), Ethypharm S. A. (France), Fresenius SE & Co. KGaA (Fresenius Kabi) (Germany), Alkermes, Inc. (Ireland), Mylan N.V. (US), and others.
China Alexipharmic Drugs Market Analysis
China's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The China Alexipharmic Drugs market will grow because the Chinese government and healthcare providers are increasing their efforts to raise public awareness about poisoning and the availability of antidotes. The key market players are Beijing Kawin Technology Share-Holding (CHN), Yino Pharma Limited (CHN), and others.
Australia Alexipharmic Drugs Market Analysis
Australia's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The rising incidence of poisonings due to accidental or intentional exposure to toxins is driving the demand for alexipharmic drugs in Australia. The key market players are CSL Behring, Hospira, Mylan, Phebra (AUS), and others.
APAC Alexipharmic Drugs Market Analysis
The APAC Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 5.97% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The APAC Alexipharmic Drugs market will grow because chronic conditions have been increasing among women, adults aged elderly population, and those living in rural areas. The key market players are CSL Limited (AUS), Otsuka Pharmaceutical (JPN), SGPharma Pvt. Ltd. (India), Sandoz International, and others.
Global Robotic Surgery Services Market Analysis
The Global robotic surgery service market size was valued at $4.29 Bn in 2022 and is estimated to expand at a CAGR of 19.3% from 2022-30 and will reach $17.63 Bn in 2030. The advantages of robotic surgery and technological developments in surgical robots are the main drivers of the surgical robot market's expansion. The robotic surgery service market will grow due to robotic surgery technology having made complex surgical procedures more accessible, especially in rural areas where access to specialized surgeons may be limited. The market is segmented by product and service type, application type, and end user. Some of the major players the prominent players in the surgical robot market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), and others.
UK Robotic Surgery Services Market Analysis
UK robotic surgery service market size was valued at $112 Mn in 2022 and is estimated to expand at a CAGR of 17.30% from 2022-30 and will reach $400 Mn in 2030. The robotic surgery service market will grow due to Robotic surgical systems providing physicians with greater accuracy and precision, which results in improved patient outcomes and reduced complications. The market is segmented by product and service type, application type, and end user. Some of the major players are Intuitive Surgical, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., and others
Spain Robotic Surgery Services Market Analysis
Spain's robotic surgery service market size was valued at $83 Mn in 2022 and is estimated to expand at a CAGR of 18.3% from 2022-30 and will reach $318 Mn in 2030. The robotic surgery service market will grow due to patients becoming more aware of the benefits of robotic surgery, such as smaller incisions, reduced blood loss, and faster recovery times, which is driving demand for these services. The market is segmented by product and service type, application type, and end user. Some of the major players are Medtronic, Johnson & Johnson, Stryker, Intuitive Surgical, and others.
France Robotic Surgery Services Market Analysis
France's robotic surgery service market size was valued at $118 Mn in 2022 and is estimated to expand at a CAGR of 18.3% from 2022-30 and will reach $453 Mn in 2030. The robotic surgery service market will grow due to the development of new and improved robotic surgical systems is making these procedures more accessible and affordable, and helping to increase awareness about their benefits among healthcare providers and patients. The market is segmented by product and service type, application type, and end user. Some of the major players are Medtronic, Johnson & Johnson, Stryker, Intuitive Surgical, Smith & Nephewand others
Philippines Connected Healthcare Market Analysis
The Philippines-connected healthcare market is projected to grow from $145.99 Mn in 2022 to $1112.63 Mn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for telemedicine services, rising healthcare costs, shortage of healthcare professionals and government support. The market is segmented by type, function and by application. Some of the major players include Ayala Healthcare, QualiMed, MyPocketDoctor, Microsoft, IBM and Siemens Healthineers.
Vietnam Oncology Drugs Market Analysis
By 2030, it is anticipated that the Vietnam oncology drugs market will reach a value of $xx Mn from $982.2 Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Vietnam is dominated by a few domestic pharmaceutical companies such as Vimedimex Medi-Pharma, OPC Pharmaceutical, and Hanoi Pharmaceutical. The oncology market in Vietnam is segmented into different therapeutic areas and different treatment types. The major factors affecting the Vietnam oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Vietnam.
Netherlands Oncology Drugs Market Analysis
By 2030, it is anticipated that the Netherlands oncology drugs market will reach a value of $xx Mn from $510.74 Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Cristal Therapeutics, ABL Europe, and Synthon. The oncology market in the Netherlands is segmented into different therapeutic areas and different treatment types. The major factors affecting the Netherlands oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most of the areas of the Netherlands.
Tanzania Neurology Devices Market Analysis
The Tanzania neurology device market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Tanzania has a high prevalence of neurological conditions like seizures, stroke, neurodegenerative diseases, neuromuscular disorders, and neuro-infections. The demand for neurology devices in the nation will rise as these diseases become more common. The market is segmented by product type and by the end user. Some key players in the market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Penumbra and Abbott Laboratories.
Nigeria Neurology Devices Market Analysis
The Nigeria Neurology Device Market is expected to witness growth from $11 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Prevalence of Neurological illnesses has increased in Nigeria, which results in increasing demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Me Cure Healthcare, Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Morocco Neurology Devices Market Analysis
The Morocco Neurology Device Market is expected to witness growth from $16 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. In Morocco, the incidence of neurological conditions like seizures, stroke, and Parkinson's disease is rising. Ageing populations, shifting lifestyle preferences, and growing public knowledge of neurological disorders all contribute to this. It is anticipated that this rising prevalence will raise the demand for Neurology Devices in Morocco. The market is segmented by product type and by the end user. Some key players in this market include Promamec, Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Mexico Neurology Devices Market Analysis
The Mexico Neurology Device Market is expected to witness growth from $189 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Mexico's population is quickly ageing, with an increase in the proportion of people over 60. Age increases a person's vulnerability to brain diseases like Alzheimer's, Parkinson's, and stroke. The demand for neurology devices used in the diagnosis and treatment of these disorders, such as neurostimulation devices and imaging systems, is anticipated to increase as a result of this demographic tendency. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
